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ABSTRACT OF THE THESIS 
Late Electrophysiological Potentials and Emotion in Schizophrenia:  
A Meta-Analytic Review 
 
by 
Mayan Castro 
Master of Arts in Social Ecology 
 
University of California, Irvine, 2019 
 
Assistant Professor Elizabeth A. Martin, Chair 
 
 
 
Introduction: There is mixed evidence about emotional processing abnormalities in 
schizophrenia and schizoaffective disorder, with trait self-reports and clinician ratings indicating 
significant differences between patients and controls, but studies of in-the-moment, self-reported 
emotional experience finding only small differences between these groups. The current meta-
analysis synthesizes statistics from studies measuring the P3 and LPP, two event-related 
potential (ERP) components sensitive to attentional allocation, to examine whether patients 
exhibit ERP response abnormalities to neutral and valenced visual stimuli. 
Methods: Standardized mean amplitudes and standard errors of P3 and/or LPP waveforms (300-
2000 ms) in response to neutral and valenced images were calculated for 13 studies (total n=339 
individuals with schizophrenia, 331 healthy controls). 
Results: In response to neutral images, there were very small, non-significant differences in ERP 
amplitudes between patient and control groups (k=9; Hedges’ g=-0.06, 95% CI: -055, 0.43, 
p=0.81). In contrast, patients showed a small, significant reduction in ERP amplitudes compared 
to controls in response to negative images (k=13; Hedges’ g=-0.32, 95% CI: -0.59, -0.05, 
viii 
 
p=0.02), and a small, but nonsignificant, reduction in amplitudes in response to positive images 
(k=7; Hedges’ g=-0.27, 95% CI: -0.71, 0.18, p=0.24).  
Conclusions and implications: The current review indicates that compared to controls, patients 
have slightly diminished P3 and LPP amplitudes in response to positive and negative stimuli. 
This small reduction may reflect decreased attention allocation, possibly indicating an 
abnormality during a distinct stage of early processing related to evaluating the motivational 
salience of a stimulus. 
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1. Introduction 
It is widely reported that individuals with schizophrenia and schizoaffective disorder 
have emotional abnormalities compared to controls (Kring and Elis, 2013; Trémeau, 2006). 
These abnormalities can have a profound negative impact on the psychosocial functioning, 
wellbeing, and overall quality of life of patients (Kohler and Martin, 2006). However, there are 
mixed reports about the nature of emotional abnormalities in schizophrenia. Some comparisons 
indicate a similar response to valenced stimuli in patients relative to controls, whereas others 
report a decreased or increased response (Cohen and Minor, 2010; Kring, 1999; Trémeau, 2006).  
Clarifying the nature of emotional abnormalities in schizophrenia is a crucial step towards 
developing targeted and effective treatments that may lead to improved emotional functioning 
for individuals with schizophrenia. 
The current meta-analytic review presents a comprehensive quantitative synthesis of 
studies that have applied the event-related potential (ERP) technique, an objective and direct 
measure of brain activity in response to stimuli, to elucidate the nature of emotional 
abnormalities in schizophrenia. Two specific ERP components, the P3 and late positive potential 
(LPP), are particularly valuable in the study of emotional functioning, as they reflect neural 
correlates of attentional allocation to emotional information (Hajcak et al., 2011) – a critical step 
in emotional regulation and emotional memory development (Gross, 2002; Talmi et al., 2007). 
1.1. Emotion in schizophrenia 
Emotional dysfunction in patients has been assessed in multiple ways, including in self-
reports of trait affect and clinician ratings, where the differences between patients and controls 
are largest. However, recently, it has been suggested that people with schizophrenia have intact 
in-the-moment, self-reported experience of positive emotion compared to control participants 
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(Kring & Moran, 2008, but see Strauss, Visser, Lee, & Gold, 2017). In a meta-analysis of 26 
studies that presented emotional stimuli, Cohen and Minor (2010) reported small differences 
between schizophrenia patients and controls in self-reported positive emotion (Hedges’ D = -
0.16). Importantly, this does not appear to be the result of insensitive measures for self-reported 
positive emotion, as other disorders associated with emotional abnormalities (e.g., major 
depressive disorder) do show significantly diminished positive responding compared to controls 
(Dunn et al., 2004; Sloan et al., 1997). At the same time, individuals with schizophrenia report 
high levels of trait negative emotion (Cohen et al., 2011), but it has also been suggested that 
patients show similar in-the-moment responses to negative stimuli as control participants (mean 
weighted effect size Hedges D’ = 0.24; Cohen & Minor, 2010). Further, “ambivalent” emotional 
responses, characterized by some as the co-activation of both positive and negative emotion and 
by others as reports of feelings inconsistent with stimulus valence, have also been widely 
reported in schizophrenia (Bleuler, 1950; Docherty et al., 2015; Trémeau et al., 2009). These 
various findings have not yet led to a clear and unifying account of the extent to which people 
with schizophrenia experience emotion differently from healthy individuals. However, objective 
and direct measures of brain activity, such as event-related potentials (ERPs), could help 
reconcile these findings and identify mechanisms that contribute to aberrant emotional 
functioning in people with psychotic disorders.  
 The ERP technique offers a method of examining emotion processing that is 
complementary to self-report, clinician ratings, and behavioral methods. By synthesizing data 
across ERP studies of emotion processing in schizophrenia, we can elucidate one of the apparent 
conflicts in the literature: the finding that differences between patients and controls are greatest 
in self-reports of trait affect and clinician ratings of emotional dysfunction, whereas self-reports 
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of in-the-moment emotion experience show much smaller differences. ERP studies of emotional 
functioning employ mixed methodologies, including passive viewing tasks and tasks wherein 
participants must respond verbally or by pressing a button. Additionally, the majority of these 
studies have small samples, making it difficult to determine whether findings support the large 
effects observed in self-reports of trait affect and clinician ratings or whether they fall more in 
line with measures of in-the-moment emotional experience. Currently, there is no comprehensive 
review of this literature, and the present article is the first quantitative analysis to examine 
studies of ERP responses to visual emotional stimuli in individuals with schizophrenia and 
healthy controls. By systematically examining objective measures of emotional experience in 
individuals with schizophrenia, this work will lead to a better understanding of patients’ 
emotional abnormalities. This can contribute to targeted interventions that improve emotional 
functioning and, consequently, improve quality of life for individuals with schizophrenia. 
The purpose of the current review is to determine whether patients and controls differ in 
magnitude in response to neutral, positive, or negative stimuli on late ERP components (P3 and 
LPP). Late ERP components are typically associated with sustained increase in attention to 
emotional information in healthy individuals (Hajcak et al., 2010). Additionally, though several 
studies have examined responses to neutral and emotional stimuli, the actual size of the 
difference between patients and controls using more objective measures remains unclear. We 
therefore seek to clarify the effect of valence by investigating potential differences between 
responses to neutral, positively, and negatively valenced emotional images, as measured by late 
ERP components. 
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1.2. ERP associated with motivational salience: P3 
The P3 component can be divided into the P3a and P3b, with the P3a typically signifying 
the orienting of attention to a novel stimulus, even among a stream of unattended stimuli 
(Näätänen and Kreegipuu, 2011). The P3b, on the other hand, is associated with the motivational 
salience of a stimulus, whether from intrinsic or extrinsic sources. The current review will focus 
on the P3b component (hereafter referred to as ‘P3’), which generally appears as a positive 
deflection over Pz starting from 250-500 ms following stimulus presentation (Hajcak et al., 
2011).   
P3 studies have traditionally used nonemotional stimuli (e.g., Xs and Os) in an oddball 
design comparing responses to infrequent ‘targets’ and frequent ‘standard’ stimuli (Polich, 
2007). Research indicates that the amplitude of the P3 is modulated by motivation, such that task 
demands and proportion of targets to standards impact the magnitude of the response to target 
stimuli (Duncan-Johnson and Donchin, 1977; Hillyard et al., 1973). More recently, researchers 
have used the P3 to examine responses to emotional stimuli in similar oddball paradigms. The 
reason the P3 lends itself well to use in emotion studies is that emotional stimuli may serve as 
“natural targets,” automatically capturing attention and requiring additional processing resources 
because of their emotional content (Hajcak et al., 2011). The inherent motivational salience of 
emotional stimuli allows researchers to include positive and negative images in P3 studies as an 
index of emotional responding.1 
 
 
                                                 
1 Although the neural origins of the P3 are a subject of continued debate, evidence from functional magnetic 
resonance imaging (fMRI), electroencephalography (EEG) source localization techniques, and intracranial 
recordings have pointed to areas in the cerebral cortex, particularly the parietal and temporal lobes, as likely sources 
of the P3 (Polich, 2007). It is plausible that the P3 is generated from a neural circuit linking these parietal and 
temporal areas, reflecting the activation of attentional and working memory systems. 
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1.3. ERP associated with sustained emotional information processing: LPP 
Another ERP component closely related to attentional allocation to emotional stimuli is 
the late positive potential (LPP). Appearing maximally over centro-parietal sites, the LPP is a 
positive-going waveform starting from 300-2000 ms post-stimulus and continuing for up to 
several seconds (Hajcak et al., 2011). Both pleasant and unpleasant stimuli elicit increased 
amplitudes of the LPP waveform compared to neutral stimuli in healthy individuals, especially in 
cases where the emotional stimuli are related to survival, injury, or death (e.g., images depicting 
erotica or mutilation; Briggs & Martin, 2009). The LPP appears to track with subjective arousal 
ratings, such that images rated as more arousing also elicit greater LPP amplitudes (Martin, Li, & 
Castro, under review; Weinberg & Hajcak, 2010). Because the LPP is considered to reflect the 
sustained attentional processing of motivationally relevant emotional stimuli, it may play an 
important role in the emotion deficits observed in schizophrenia.2  
1.4. The current study 
The goal of the current meta-analytic review was to establish whether there are 
significant differences in responses to neutral, positively, or negatively valenced visual stimuli in 
individuals with schizophrenia and schizoaffective disorder compared to healthy controls using 
the P3 and LPP waveform amplitudes. In addition, the current review investigated the role of 
other variables across studies and samples that may potentially moderate these effects, such as 
measurement approach, time window examined, task procedures, and image content (see 
Appendix C). These variables were chosen for moderator analyses, as they represent the task and 
participant characteristics often controlled in patient studies. 
 
                                                 
2 Efforts to localize the origins of the LPP in the brain using fMRI and EEG techniques have led to the 
understanding that brain areas involved in emotional processing (i.e., ventrolateral prefrontal cortex, insula, and 
prefrontal cortex) may serve as potential LPP generators (Liu et al., 2012; Sabatinelli et al., 2013).   
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2. Materials and method 
 The current meta-analysis followed PRISMA guidelines (Moher et al., 2009) for 
transparent and replicable methods and findings. Please see Appendix A, Supplementary Table 1 
for the PRISMA checklist.  
2.1. Eligibility criteria for meta-analysis 
Inclusion criteria for the current analyses were as follows: 1) the study included a sample 
of patients meeting DSM-III-R (American Psychiatric Association, 1987) or DSM-IV-TR 
(American Psychiatric Association, 2000) criteria for schizophrenia or schizoaffective disorder; 
2) the study included a nonpsychiatric control sample (i.e., individuals with no history of 
psychopathology determined by a screening or diagnostic interview); 3) the stimuli used in the 
study included positively or negatively valenced visual images (e.g., faces, scenes, objects); 4) at 
least one of the ERP components of interest (P3 and LPP, from 300-2000 ms) was measured; 5) 
mean amplitudes or peak amplitudes were reported for the P3/LPP waveforms for patients and 
control subjects; 6) statistics were reported that allowed for calculation of effect size 
(standardized mean difference between groups) of P3/LPP ERP waveform amplitude (or the 
authors provided us with this information, upon request); and 7) study findings were reported in 
a peer-reviewed journal article in English. Studies were excluded if they did not meet inclusion 
criteria. There were no other exclusion criteria. The literature search took place between October 
19, 2015 and August 3, 2017.3 
                                                 
3 We used the Risk of Bias Assessment Tool for Nonrandomized Studies (RoBANS) (Kim et al., 2013) to evaluate 
risk of bias in individual studies. Two raters (M. Castro and E. Martin) completed independent ratings of each study 
with good inter-rater agreement (87% agreement, Cohen’s kappa=0.66). Scoring discrepancies were resolved by 
consensus ratings (M. Castro and E. Martin). For the majority of studies, risk of potential bias was low. A summary 
of the RoBANS data can be found in Appendix A, Supplementary Table 2. 
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In response to the variability in ERP nomenclature across studies, we distinguished the 
P3 and LPP ERP components by time course and topography.4  
2.2. Information sources, search terms, and study selection 
We searched the online databases PubMed, PsycINFO, and Google Scholar for relevant 
studies using the following search terms: schiz* AND (EEG OR ERP) AND (P3 OR LPP OR 
late positive complex OR late positive component OR LPC OR late positivity) AND (emotion* 
OR affect*). The articles resulting from this search were examined for eligibility, and articles 
referenced by or referencing each article resulting from the computer search were also examined 
for eligibility for the meta-analysis. Furthermore, we contacted experts in the field with more 
than two articles identified in the keyword searches for any additional articles meeting our 
criteria. We contacted the corresponding author of the study when the information needed to 
calculate effect size was not reported in the article.5 Figure 1 shows a PRISMA flow diagram of 
systematic search and study selection (Moher et al., 2009). 
                                                 
4 The P3 was categorized as a positive-going waveform, recorded at midline parietal sites, that peaks approximately 
300-500 ms following the presentation of a visual stimulus. Likewise, the LPP was categorized as a positive 
deflection, recorded at midline centroparietal sites, that is evident after 300 ms following the onset of a visual 
stimulus and that may continue for 2000 ms or more following stimulus presentation. 
5 All articles were examined for overlapping samples. When multiple articles were written by the same research 
group, samples were examined to ensure they were not overlapping. When articles reported responses to more than 
one image type (k = 11), the samples used were the same for all image types. 
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Figure 1. PRISMA flow diagram of systematic search and study selection (Moher et al., 2009). 
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2.3. Data analysis plan 
 The primary variables of interest were mean amplitudes of P3 and/or LPP waveforms to 
neutral, positive, or negative visual stimuli in individuals with schizophrenia compared to 
healthy controls. Standardized mean amplitudes, standard error, and 95% confidence interval 
(CI) of P3 and/or LPP waveforms were calculated for each study. All analyses were conducted in 
the statistical software program R (R Development Core Team, 2011), using the metafor package 
for meta-analysis (Viechtbauer, 2010).  
 Estimates were calculated using a random-effects model and the Q statistic was used to 
test for heterogeneity of the effect size distributions. Funnel plots graphing the effect sizes of 
each study against the study’s sample size were created and Egger’s regression test of funnel plot 
asymmetry was used to assess publication bias. Bias is unlikely in this analysis, as the contrast 
examined here is not the primary effect of interest in most of the included studies. For example, 
one study examined ERPs and empathic responses in patients (Corbera et al., 2014). The 
partitioned Q statistic was used to examine the effects of potential moderators. 
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3. Results 
3.1. Characteristics of included studies and samples 
 Information about the characteristics of included studies is shown in Table 1 and 
Appendix C, Supplementary Table 3.6 
                                                 
6 Information on medication dosing was reported in six studies, and symptom ratings were reported in seven studies. 
Patients were excluded based on history of neurological conditions (11 studies), head injury (five studies), current 
substance abuse (seven studies), or intellectual disability (six studies). Inclusion criteria for nonpsychiatric control 
samples included screening for DSM-IV-TR (American Psychiatric Association, 2000) Axis I psychotic conditions 
using a structured or semi-structured clinical interview (seven studies) and/or screening for DSM-IV-TR Axis II 
conditions (nine studies). Control participants were also excluded for recent history of substance abuse (seven 
studies), family history of psychotic disorder (five studies), history of neurological disorder (nine studies), or history 
of head injury (five studies). 
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Table 1 
Study Characteristics (K = 13) 
 
 Demographic Data 
 Patients  Controls 
Study  n 
Mean 
age 
(years) 
Sex 
(% 
male) 
Mean 
education 
(years)  n 
Mean 
age 
(years) 
Sex 
(% 
male) 
Mean 
education 
(years) 
    
An et al. (2003)  20 31.4 
(8.8) 
60 14.0 (2.1)  20 27.3 
(7.1) 
55 14.7 (2.1) 
Andersen et al. 
(2015) 
 31 24.8 
(5.2) 
83.9 4.2 (1.6)  47 26.8 
(7.0) 
53.2 3.2 (1.4) 
Corbera et al. 
(2014) 
 19 46.05 
(9.37) 
42 13.42 
(2.12) 
 18 39.78 
(8.61) 
67 15.61 
(2.59) 
Herrmann et al. 
(2006) 
 22 31.7 
(8.4) 
77 10.3  22 31.9 
(11.0) 
77 9.9 
Horan et al. (2010)  38 44.5 
(10.6) 
81.6 12.8 (1.5)  36 38.5 
(10.3) 
74.3 14.7 (1.5) 
Horan et al. (2012)  35 48.3 
(7.6) 
74.3 13.2 (1.6)  26 44.9 
(8.5) 
73.1 14.5 (1.7) 
Horan et al. (2013)  31 47.8 
(9.8) 
75 12.5 (1.9)  27 45.5 
(6.7) 
77.4 14.9 (1.3) 
Jung et al. (2012)  23 32.2 
(10.1) 
52.2 12.8 (2.1)  24 38.0 
(11.9) 
50 13.0 (2.9) 
Kim et al. (2015)  21 37.57 
(11.37) 
52.4 12.44 
(2.33) 
 18 40.83 
(12.07) 
44.4 14.17 
(4.13) 
Lee et al. (2010)  38 30.2 
(10.3) 
42.1 13.0 (2.3)  38 34.2 
(11.9) 
47.4 14.1 (2.9) 
Okruszek et al. 
(2016) 
 26 28.2 
(6.4) 
69.2 NR  21 24.7 
(6.0) 
71.4 NR 
Turetsky et al. 
(2007) 
 16 30.5 
(6.0) 
75 12.5 (1.8)  16 28.1 
(5.4) 
75 17.1 (2.5) 
Wexler et al. 
(2014) 
 19 46.05 
(2.1) 
42.1 13.4 (0.5)  18 39.7 
(2.0) 
66.7 15.6 (0.6) 
Total  339 36.9 
(8.5) 
63.6 12.0 (2.6)  331 35.4 
(7.0) 
64.0 13.4 (3.7) 
 
Note: Means are presented with accompanying standard deviations in parentheses. Totals are unweighted by 
sample size. NR: not reported. 
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3.2. Results for responses to neutral visual stimuli 
The results for responses to neutral visual stimuli for the patient and control groups are 
summarized in Table 2, and a corresponding forest plot of the effect size and 95% confidence 
interval (CI) for each study is presented in Figure 2. 
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Figure 2. Forest plot of the effect size and 95% confidence interval (CI) for each study using 
neutral images. 
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As shown in Table 2, the weighted mean Hedges’ g effect size of the nine studies examining 
responses to neutral images was not significant (Hedges’ g = -0.06, p=0.807), and the 
distribution of effect sizes was significantly heterogeneous (Qtotal(8) = 70.45, p < 0.001; I2 = 
91.99%). The funnel plot appeared symmetrical (see Appendix B, Supplementary Figure 1), and 
Egger’s test of funnel plot asymmetry was not statistically significant (z = -0.02, p = 0.98), 
suggesting limited influence of publication bias. 
3.3. Results for responses to positive visual stimuli 
The results for studies using positive images are shown in Table 2. A forest plot of the 
effect size and 95% CI for each study is presented in Figure 3. 
 
 
Figure 3. Forest plot of the effect size and 95% confidence interval (CI) for each study using 
positive images. 
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As can be seen in Table 2, the weighted mean Hedges’ g effect size of the seven positive-
image studies was not significant (Hedges’ g = -0.27, p = 0.242), and the distribution of effect 
sizes was significantly heterogeneous (Qtotal(6) = 22.24, p = 0.0011; I2 = 87.53%). The funnel 
plot appeared asymmetrical (see Appendix B, Supplementary Figure 1), but Egger’s test of 
funnel plot asymmetry was not statistically significant (z = 0.51, p = 0.61), indicating that 
publication bias was unlikely to influence effect size. 
3.4. Results for responses to negative visual stimuli 
Table 2 shows the results for responses to negatively valenced visual stimuli for the 
patient and control groups. A forest plot of the effect size and 95% CI for each study is presented 
in Figure 4.  
 17 
 
 
Figure 4. Forest plot of the effect size and 95% confidence interval (CI) for each study using 
negative images. 
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As seen in Table 2, there was a small weighted mean Hedges’ g effect size of the 13 
studies examining responses to negative images. The amplitude of the patient group was smaller 
than that of the control group, and the effect size was significantly different from zero (Hedges’ 
g = -0.32, p = 0.0196). There was significant heterogeneity in the distribution of effect sizes 
(Qtotal(12) = 46.60, p < 0.001; I2 = 75.47%). The funnel plot appeared mostly symmetrical (see 
Appendix B, Supplementary Figure 1). There was no evidence of a significant influence of 
publication bias, analyzed using Egger’s test of funnel plot asymmetry (z = -0.02, p = 0.98). 
For negative image studies, we conducted additional analyses of measurement approach, 
time window examined, task procedures, and image content as possible moderators. Though 
these results should be interpreted with caution given the small number of available studies, 
analyses indicated that measurement approach, time window examined, and task procedures did 
not account for proportion of heterogeneity of effect sizes. Image content did appear to be a 
significant moderator, with studies using other (non-face) images having smaller mean effect 
sizes than studies using images of faces, on average. More information regarding moderator 
analyses can be found in Appendix C and Table 3. 
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Table 3 
Moderator Analyses  
 
 
 
Studies Using Negative Images (K = 13) 
 
Moderator  Q p Effect size (SE) 
 
 
Measurement 
approach 
 
 
0.02 0.88 
Mean: -0.33 (0.18) 
 
Peak: -0.20 (0.16) 
 
Time window 
examined 
 
 1.64 0.20 
Extended P3: -0.58 (0.18) 
 
Conventional P3: -0.18 (0.18) 
 
Task 
procedures 
 
 0.40 0.53 
Passive: -0.61 (0.40) 
 
Response: -0.30 (0.15) 
 
Image content 
 
 3.99 0.04 
Faces: -0.11 (0.19) 
 
Other: -0.62 (0.16) 
Note: SE: Standard error. Measurement approach: whether the study used mean or peak ERP amplitudes. 
Time window examined: “extended P3,” wherein the time window measured had minimal overlap (< 
32%) with the conventional P3 time window (i.e., the majority of time measured was after 500 ms) or 
“conventional P3”, wherein more than 32% of the total time window measured fell within the 
conventional P3 time window. Task procedures: whether study used a passive viewing or response 
required paradigm during ERP recording. Image content: whether study used images of faces only or used 
“other” images including people, objects, and scenes. Bold values represent statistically significant 
moderators. 
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4. Discussion 
The results of this meta-analysis suggest a small possible disruption in attentional 
allocation to valenced visual stimuli in schizophrenia and schizoaffective disorder. At the same 
time, patients and controls responded almost identically to neutral stimuli, indicating a potential 
abnormality in early attentional allocation may be specific to valenced visual information. Based 
on the available information, the current findings have implications for how we conceptualize 
dysfunction in schizophrenia spectrum disorders. 
4.1. Small, nonsignificant differences between patients and controls to neutral visual stimuli 
The present analyses found a very small, nonsignificant difference between the P3 and 
LPP responses of patients with schizophrenia or schizoaffective disorder and healthy controls in 
response to neutral visual stimuli. Thus, as opposed to evidence of increased amygdala activation 
to neutral stimuli in individuals with schizophrenia (Kring and Barch, 2014; Kring and Elis, 
2013) or self-reports of higher positive and negative emotion coactivation in response to neutral 
stimuli compared to controls (Cohen and Minor, 2010), the results from this meta-analysis 
suggest similar early attentional allocation to neutral stimuli between the groups. Given that 
some techniques (i.e., functional magnetic resonance imaging, self-report) assess functioning at 
different stages of emotion processing (Berkman et al., 2014), they may allow for biases and 
beliefs about emotion to influence responses. This is in contrast to ERP measurement, which is a 
more direct assessment of early attention (Hajcak et al., 2010) that is less likely to be influenced 
by beliefs. These findings taken together suggest that there may be a distinct time course of 
emotion abnormities in schizophrenia.  
In general, it would be important for researchers to incorporate a neutral condition that is 
methodologically consistent with other conditions when investigating responses to emotional 
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stimuli in future studies. Studies examined for this review were not always consistent in their 
conceptualization and measurement of responses to neutral and emotional stimuli. As a result, 
only studies with neutral conditions that were procedurally similar to emotion conditions were 
included in the analyses (k = 9). Differences between task procedures for neutral and emotional 
stimuli may complicate efforts to distinguish results related specifically to the emotional nature 
of stimuli. Including neutral stimuli and maintaining consistent task procedures across stimulus 
types makes it possible to draw more robust conclusions about whether differences between 
patients and controls actually reflect a deficit specific to emotion processing, or whether patients 
show an overall blunting of ERPs in response to visual stimuli. However, the current finding that 
both groups show similar responses to neutral images suggests that individuals with 
schizophrenia have relatively intact processing through the first several thousand milliseconds of 
viewing for neutral stimuli, and that any abnormalities found in response to emotional images 
(i.e., positive or negative images) may be attributable to the specifically emotional nature of 
those images. 
4.2. Small, nonsignificant reduction in response to positive visual stimuli in patients  
 The current meta-analysis found a small, nonsignificant reduction in response to 
positively valenced visual stimuli for individuals with schizophrenia or schizoaffective disorder 
compared to healthy controls. Although nonsignificant, the effect size was of similar magnitude 
as the size of the difference between patients and controls in response to negative image studies. 
It is possible that, while the effect sizes were similar for positive and negative image studies, the 
current analysis had insufficient power to detect significant differences in the case of positive 
image studies because there were fewer available studies to include in the analysis (Gelman and 
Stern, 2006). Thus, the fact that positive and negative image studies had similar effect sizes may 
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be more meaningful than the fact that only responses to negative images were statistically 
significant.  
The finding of a small reduction in response to positively valenced images for individuals 
with schizophrenia is largely consistent with literature indicating no differences between patients 
and controls in self-reported positive affect in response to positive stimuli (Cohen and Minor, 
2010), and also supports the theory that in-the-moment positive emotion is largely intact in 
people with schizophrenia (Cohen et al., 2011; Gard et al., 2007; Kring and Moran, 2008; Strauss 
et al., 2017). 
Although current findings suggest only a small abnormality with respect to attentional 
allocation to positive stimuli, differences regarding positive emotions between individuals with 
schizophrenia spectrum disorders and healthy controls may emerge at later stages of processing. 
For example, a deficit in sustained (as opposed to initial) attention to positive information may 
be related to findings that schizophrenia is associated with memory impairment for emotional 
experiences, particularly over long time periods (Herbener, 2008). This is because sustained 
attentional allocation involves “embellishing” stimuli and linking them to other information 
(Anderson, 2005), deepens encoding of to-be-remembered information (Anderson and Reder, 
1979). This process, sometimes referred to as elaborative processing, persists for a minimum of 
several seconds (e.g., Martin, Siegle, Steinhauer, & Condray, 2018; Siegle, Condray, Thase, 
Keshavan, & Steinhauer, 2010) and results in more durable and easily recalled memories than 
non-elaborated material (Anderson, 2005; Craik and Lockhart, 1972). Thus, impaired sustained 
attention to positive information could contribute to a downstream deficit in memory for 
emotional information in schizophrenia. Relatedly, deficits in memory encoding and retrieval 
(Strauss and Gold, 2012), as well as abnormal elaborative processing (Martin et al., 2018), have 
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been linked to low-pleasure beliefs, or beliefs that one does not generally experience pleasure or 
that certain activities and events are not pleasurable. Low pleasure beliefs have been associated 
with anhedonia (Yang et al., 2018) and may partially account for the findings that individuals 
with schizophrenia report diminished experience of positive affect compared to healthy 
individuals (Kring and Moran, 2008). Self-reported desires to attend to or ignore emotions also 
show large differences between patients and controls (Martin et al., 2013), which supports the 
theory that subjective awareness of attentional allocation (to a sufficient extent such as to allow 
self-report) may become most apparent later in processing, when these downstream differences 
arise. 
4.3. Small reduction in response to negative visual stimuli in patients 
The findings of the current analysis indicate that patients showed a small, significant 
reduction in attention allocation to negative images compared to controls. At the same time, 
individuals with schizophrenia or schizoaffective disorder consistently report higher levels of 
negative emotion compared to control participants (Horan et al., 2008; Trémeau, 2006). 
Considering these results together, it is possible that because patients have significantly higher 
trait negative affect, they allocate less attention to negative information because it is their 
“norm.” That is, given that their baseline level of negative affect is already high, negative stimuli 
do not capture their attention in the same way as they do for control participants. Consistent with 
this theory, it is widely reported that individuals show diminished responses to familiar stimuli 
across a variety of biological systems (Bradley et al., 1993). Thus, it is possible that patients do 
not allocate attention to negative stimuli to the same extent as control participants, because the 
stimuli lack the same novelty.    
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Consistent with the current findings for schizophrenia, blunted P3 and LPP waveforms to 
negative stimuli have been reported in groups at risk for psychopathology as well as in 
individuals already diagnosed with a disorder. For example, Strauss and colleagues (2018) found 
diminished LLP amplitudes in individuals who are at ultra high-risk for psychosis. A similar 
finding has also been reported for individuals at risk for depression (Kayser et al., 2017) and 
those with psychopathic traits (Medina et al., 2016). Additionally, individuals with major 
depression (Foti et al., 2010) or non-psychotic bipolar I disorder during an episode of mania 
(Ryu et al., 2010) show reductions in these later ERP components in response to unpleasant 
stimuli. Thus, measures of attentional allocation to negative stimuli may indicate risk for or 
current psychopathology. 
4.4. Limitations and conclusions 
 Despite adherence to the PRISMA guidelines (Moher et al., 2009) for transparent and 
replicable methods and findings, there are some limitations to the current review. Unpublished 
manuscripts were solicited, but no manuscripts eligible for inclusion were found, and 
information required for inclusion was not available for all eligible studies. Additionally, there 
were insufficient details regarding sample characteristics, such as symptom levels, duration of 
illness, functional impairment, and medication dosage information, to test these as potential 
moderators across all studies. These may be potential sources of the significant heterogeneity of 
the effect size distribution detected in response to all image types. Additionally, the results 
generalize only to adult populations, as none of the included studies involved participants under 
the age of 18.  
Despite these limitations, the current review is the first to show that initial attention 
allocation to positive and negative images is slightly diminished in schizophrenia and 
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schizoaffective disorder. The size of the difference between patients and controls for valenced 
stimuli was small, with patients showing slightly blunted ERP waveforms. The disruption of 
attention allocation to valenced stimuli, coupled with the finding of intact early-stage responding 
to neutral images, suggests that impaired initial allocation of attention may be specific to 
valenced stimuli in schizophrenia. Thus, the analysis presented here contributes to furthering the 
current understanding of abnormal emotional processing in schizophrenia spectrum disorders. 
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Appendix A 
PRISMA Checklist and Risk of Bias Assessment 
 
Section/topic  # Checklist item  Reported 
on page 
#  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: background; 
objectives; data sources; study eligibility criteria, participants, and 
interventions; study appraisal and synthesis methods; results; 
limitations; conclusions and implications of key findings; systematic 
review registration number.  
2 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is 
already known.  
3-5 
Objectives  4 Provide an explicit statement of questions being addressed with 
reference to participants, interventions, comparisons, outcomes, 
and study design (PICOS).  
5, 7 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be accessed 
(e.g., Web address), and, if available, provide registration 
information including registration number.  
NA 
Eligibility 
criteria  
6 Specify study characteristics (e.g., PICOS, length of follow-up) and 
report characteristics (e.g., years considered, language, publication 
status) used as criteria for eligibility, giving rationale.  
8 
Information 
sources  
7 Describe all information sources (e.g., databases with dates of 
coverage, contact with study authors to identify additional studies) 
in the search and date last searched.  
9 
Search  8 Present full electronic search strategy for at least one database, 
including any limits used, such that it could be repeated.  
9 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, 
included in systematic review, and, if applicable, included in the 
meta-analysis).  
9, Figure 1 
Data collection 
process  
10 Describe method of data extraction from reports (e.g., piloted forms, 
independently, in duplicate) and any processes for obtaining and 
confirming data from investigators.  
9-10 
Data items  11 List and define all variables for which data were sought (e.g., 
PICOS, funding sources) and any assumptions and simplifications 
made.  
8 
 
 
 
 
 
 
 
 
Supplementary Table 1. PRISMA checklist for transparent and replicable methods and 
findings. 
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Synthesis of 
results  
14 Describe the methods of handling data and combining results of 
studies, if done, including measures of consistency (e.g., I2) for each 
meta-analysis.  
11-12 
Risk of bias 
across studies  
15 Specify any assessment of risk of bias that may affect the 
cumulative evidence (e.g., publication bias, selective reporting 
within studies).  
10-12 
Additional 
analyses  
16 Describe methods of additional analyses (e.g., sensitivity or 
subgroup analyses, meta-regression), if done, indicating which were 
pre-specified.  
Supple- 
mentary 
material 
(moderator 
analyses) 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and 
included in the review, with reasons for exclusions at each stage, 
ideally with a flow diagram.  
9, Figure 1 
Study 
characteristics  
18 For each study, present characteristics for which data were 
extracted (e.g., study size, PICOS, follow-up period) and provide the 
citations.  
10, Tables 
1, 2, 4 
Risk of bias 
within studies  
19 Present data on risk of bias of each study and, if available, any 
outcome level assessment (see item 12).  
Supple-
mentary 
Table 2 
Results of 
individual 
studies  
20 For all outcomes considered (benefits or harms), present, for each 
study: (a) simple summary data for each intervention group (b) 
effect estimates and confidence intervals, ideally with a forest plot.  
Table 2, 
Figure 2 
Synthesis of 
results  
21 Present results of each meta-analysis done, including confidence 
intervals and measures of consistency.  
10-12, 
Table 2, 
Figure 2 
Risk of bias 
across studies  
22 Present results of any assessment of risk of bias across studies 
(see Item 15).  
10-12 
Additional 
analysis  
23 Give results of additional analyses, if done (e.g., sensitivity or 
subgroup analyses, meta-regression [see Item 16]).  
Supple- 
mentary 
material 
(moderator 
analyses); 
Table 3 
DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the strength of evidence for 
each main outcome; consider their relevance to key groups (e.g., 
healthcare providers, users, and policy makers).  
12-17 
 
 
 
 
 
 
 
 
Risk of bias in 
individual 
studies  
12 Describe methods used for assessing risk of bias of individual 
studies (including specification of whether this was done at the 
study or outcome level), and how this information is to be used in 
any data synthesis.  
8, Supple- 
mentary 
Table 2 
Summary 
measures  
13 State the principal summary measures (e.g., risk ratio, difference in 
means).  
9-10 
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Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), 
and at review-level (e.g., incomplete retrieval of identified research, 
reporting bias).  
17 
Conclusions  26 Provide a general interpretation of the results in the context of other 
evidence, and implications for future research.  
12-17 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other 
support (e.g., supply of data); role of funders for the systematic 
review.  
NA 
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Supplementary Table 2. Risk of Bias Assessment Tool for Nonrandomized Studies (RoBANS; 
Kim et al., 2013) ratings of potential for bias within studies. 
 
Study 
1. Selection 
of 
participants 
2. 
Confoundin
g variables 
3. 
Measuremen
t of exposure 
4.  Blinding 
of outcome 
assessment 
5. 
Incomplete 
outcome 
data 
6.  Selective 
outcome 
reporting 
An et al. 
(2003) LR LR LR UR LR LR 
Andersen et 
al. (2015) UR LR LR UR LR LR 
Corbera et 
al. (2014) LR LR LR UR UR LR 
Herrmann et 
al. (2006) UR LR LR UR UR LR 
Horan et al. 
(2012) LR LR LR UR LR LR 
Horan et al. 
(2013) LR LR LR UR UR LR 
Horan et al. 
(2010) LR LR LR UR LR LR 
Jung et al. 
(2012) LR LR LR UR UR LR 
Kim et al. 
(2015) LR LR UR UR UR LR 
Lee et al. 
(2010) LR LR LR UR UR LR 
Okruszek et 
al. (2016) UR LR LR UR LR LR 
Turetsky et 
al. (2007) LR LR LR UR UR LR 
Wexler et al. 
(2014) LR LR LR UR LR LR 
Note: LR: low risk. UR: unclear risk. Inter-rater reliability of RoBANS ratings: 87% agreement; 
Cohen’s kappa=0.66; SE of kappa=0.10; 95% CI: 0.475, 0.855; strength of agreement considered 
‘good.’ 
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Appendix B 
Funnel Plots for All Included Studies 
Supplementary Figure 1. Funnel plots of effect sizes. 
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Appendix C 
Moderator Information and Analyses 
1. Moderators examined 
 Each article was coded for several experimental and sample-level variables that could 
serve as potential moderators (coding workbook available from the corresponding author upon 
request). Based on the information accessible from the articles (or from the authors directly, 
when the information was not presented in the article), the following variables were tested as 
moderators: ERP extraction method (mean vs. peak amplitude); time window measured in the 
study (300-500 ms vs. 300-2000 ms and beyond, corresponding to conventional definitions of 
the P3 and LPP components, respectively); type of task (passive viewing vs. response required); 
and stimulus image content type (faces only vs. other images, including people, objects, and 
scenes). There were insufficient data to test symptomatology, duration of illness, or parental 
education level as potential moderators. Importantly, none of the included studies examined ERP 
responses in individuals under the age of 18. For this reason, the current findings apply only to 
adult populations. 
2. Results of moderation analyses 
To test for the effects of potential moderators on effect size, we conducted several 
subsequent analyses. However, all moderator analyses should be interpreted with caution, given 
the small number of included studies. We examined moderators only for responses to negatively 
valenced stimuli, as there were not enough studies examining responses to neutral or positive 
stimuli to conduct moderation analyses (The Cochrane Collaboration, 2011). 
As seen in Table 3, measurement approach used in the study, examined as mean 
amplitude (k = 10) vs. peak amplitude (k = 3), was not a significant moderator. Additionally, 
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time window measured in the study, calculated as percentage of overall time window falling 
within the conventional P3 time window (300-500 ms), did not account for a significant 
proportion of the heterogeneity of effect sizes. Similarly, task procedures, calculated as passive 
viewing (k = 2) vs. response required (k = 11), was not a significant moderator for studies using 
negative stimuli  
Lastly, the content of stimulus images used in the study, comparing studies that used 
images of faces only (k = 6) with studies using any other types of images (e.g., International 
Affective Picture System (Lang et al., 2008) slides of people, objects, and scenes; k = 7) did 
account for a significant proportion of the heterogeneity of effect sizes (see Table 3; amount of 
heterogeneity accounted for, R2 = 34.98%; QContent(1) = 3.99, p = 0.046). Studies using other 
(non-face) images accounted for this moderation effect, as they had smaller mean effect sizes 
than studies using images of faces, on average. 
3. Discussion of moderation effects 
Measurement approach was not a significant moderator in studies using negative images. 
Twelve studies measured mean amplitude, while only three measured peak amplitude. As a 
result, there may not have been enough studies measuring peak amplitude to detect a potential 
moderating effect of measurement approach. Percentage of overall time window falling within 
the conventional P3 time window also did not account for a significant proportion of the 
heterogeneity of effect sizes. Task procedures, defined by whether studies used passive viewing 
or response required tasks, similarly was not a significant moderator for studies using negative 
images.  
The final moderator examined was the content of stimulus images used in the study. For 
studies that used images of faces only, the mean effect size was larger than for studies using 
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other types of images (i.e., pictures of people, objects, and scenes). This finding supports an 
earlier meta-analysis of studies examining ERPs to emotional images of faces (McCleery et al., 
2015), which found that individuals with schizophrenia show a significant disruption of ERPs 
associated with early sensory processing of emotional face images compared to healthy controls. 
This impairment has been identified at the behavioral level, as well (Kohler et al., 2010; Savla et 
al., 2013), and may be related to the marked deficit in social cognition associated with 
schizophrenia. 
Of note, a number of other patient characteristic factors that might be related to ERP 
component amplitude were not able to be tested in the current meta-analysis because too few 
studies that reported this information. In particular, data regarding duration of illness and level of 
functional impairment would be informative, as these variables have been previously linked to 
emotional experience, emotional expression, and social functioning in schizophrenia and 
schizoaffective disorder (Martin et al., 2015; Mueser et al., 1996; Shtasel et al., 1992). Thus, 
future research should aim to report this information in order to test for such moderation effects.  
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